Cargando…
Questions asked in the everyday practice: immune checkpoint inhibitors
Autor principal: | Haanen, John B A G |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6045736/ https://www.ncbi.nlm.nih.gov/pubmed/30018813 http://dx.doi.org/10.1136/esmoopen-2018-000395 |
Ejemplares similares
-
Immune checkpoint inhibitors for every patient with non-small cell lung cancer? Update on immunotherapy in patients with lung cancer
por: Vansteenkiste, Johan F
Publicado: (2018) -
ESMO20 YO for YO: highlights on immune checkpoint blockade for triple-negative breast cancer
por: Punie, K., et al.
Publicado: (2020) -
ASCO: practice changing studies in gastrointestinal cancer
por: Prager, Gerald
Publicado: (2017) -
ESMO20 YO for YO: highlights on adjuvant CDK4/6 inhibitors in early hormone receptor-positive/HER2-negative breast cancer
por: Matikas, A., et al.
Publicado: (2020) -
Current highlights in lung cancer in 2021
por: Lim, K.H.J., et al.
Publicado: (2021)